Celldex Therapeutics (CLDX) - Shares outstanding

Number of shares outstanding as of December 2025 : 66,420,000

According to Celldex Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 66,420,000. At the end of 2025 the company had 66,420,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Celldex Therapeutics from 2019 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	66.42 M	0.1%
2024	66.35 M	40.4%
2023	47.26 M	0.27%
2022	47.13 M	0.94%
2021	46.69 M	17.98%
2020	39.57 M	140.71%
2019	16.44 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Seagen SGEN	188,135,000	183.25%	🇺🇸 USA
Agenus AGEN	31,886,000	-51.99%	🇺🇸 USA
Emergent BioSolutions EBS	53,200,000	-19.90%	🇺🇸 USA
Amgen AMGN	538,000,000	710.00%	🇺🇸 USA
Pfizer PFE	5,685,000,000	8,459.17%	🇺🇸 USA
GlaxoSmithKline GSK	2,017,000,000	2,936.74%	🇬🇧 UK
Titan Pharmaceuticals TTNP	1,065,000	-98.40%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Celldex Therapeutics (CLDX)

Number of shares outstanding as of December 2025 : 66,420,000